DIA Fall 2018 Meetings

DIA strives to bring you the most up-to-date information in the life sciences field to help broaden your knowledge, enhance your skillset, and advance your career. Each of our specialty meetings are designed to promote knowledge-sharing through interactive sessions with expert speakers, networking during our breaks and evening receptions, and access to others in their field looking to find solutions to combat similar challenges. This fall we will be hosting numerous events in order to help you and your peers turn ideas into action.

Biosimilars Virtual Conference Series

New this year, DIA will be hosting a virtual conference on biosimilars and their impact around the world through three different and unique sessions: Barriers to Uptake of Biosimilars in the US, Biosimilar Reimbursement in the US Marketplace, and Biosimilars in China. Join us for all three, or pick and choose which course best fits your needs.

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of study endpoints during analysis of clinical evidence in the various types of drug approval processes. Address critical questions and generate potential solutions to challenges associated with study endpoints and outcomes.

Measuring Impact in Patient Centered Drug Development

Explore how sponsor companies and patient organizations can build their abilities to measure the effectiveness of patient-centric efforts and discuss how peers have measured the impact of their patient engagement efforts at multiple stages throughout the medicines lifecycle.

Complex Drug-Device Generic Combination Products

Join FDA staff from the CDER Office of Generic Drugs (OGD), the Office of Pharmaceutical Quality (OPQ), CDRH, the Office of Combination Products (OCP), and industry experts to discuss the knowns, unknowns, and the role of modeling in the development of generic drugs.

Combination Products Conference

Discuss in-depth the recent and ongoing changes in the regulatory ecosystem for combination product development and approval, including new FDA guidances, implementation status of PDUFA VI commitments around combination products, global regulatory changes, and more.

DIA Canadian Annual Meeting

Bringing together key stakeholders from the drug, device, and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.

Real World Evidence Conference

This conference explores innovative approaches to applying RWE across the healthcare product spectrum. Expert speakers will dive into examples of unique applications of RWE, and describe novel ways stakeholders are leveraging RWE to advance healthcare knowledge and decision-making. 

We've even released a few events for 2019 to get you prepared for the upcoming year!

DIA 2019
FacebookLinkedInTwitterInstagramYouTube

Follow RXinsider on Social Media